Piers Patten

5.1k total citations
72 papers, 1.2k citations indexed

About

Piers Patten is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Piers Patten has authored 72 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Genetics, 39 papers in Pathology and Forensic Medicine and 24 papers in Oncology. Recurrent topics in Piers Patten's work include Chronic Lymphocytic Leukemia Research (49 papers), Lymphoma Diagnosis and Treatment (38 papers) and CAR-T cell therapy research (17 papers). Piers Patten is often cited by papers focused on Chronic Lymphocytic Leukemia Research (49 papers), Lymphoma Diagnosis and Treatment (38 papers) and CAR-T cell therapy research (17 papers). Piers Patten collaborates with scholars based in United Kingdom, United States and Canada. Piers Patten's co-authors include Stephen Devereux, Andrea G.S. Buggins, Ghulam J. Mufti, Deborah Yallop, J R Salisbury, Julie Richards, Chris Fegan, Andrew Wotherspoon, Terry J. Hamblin and Anna Schuh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Piers Patten

62 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Piers Patten United Kingdom	16	867	602	492	315	231	72	1.2k
Daniela Gottardi Italy	11	605 0.7×	379 0.6×	405 0.8×	193 0.6×	353 1.5×	19	1.0k
Mohammed Farooqui United States	17	1.3k 1.5×	964 1.6×	746 1.5×	293 0.9×	276 1.2×	53	1.6k
Eugen Tausch Germany	18	686 0.8×	536 0.9×	309 0.6×	188 0.6×	308 1.3×	72	1.0k
K Owusu-Ankomah United Kingdom	14	1.3k 1.5×	1.1k 1.8×	761 1.5×	331 1.1×	179 0.8×	17	1.6k
Mariela Sivina United States	18	1.5k 1.7×	947 1.6×	778 1.6×	367 1.2×	649 2.8×	39	2.0k
Johannes Bloehdorn Germany	14	581 0.7×	437 0.7×	320 0.7×	137 0.4×	320 1.4×	34	891
Yvona Brychtová Czechia	19	704 0.8×	450 0.7×	385 0.8×	294 0.9×	422 1.8×	71	1.2k
Sergey Krysov United Kingdom	15	671 0.8×	535 0.9×	472 1.0×	173 0.5×	354 1.5×	25	1.0k
Candida Vitale Italy	16	413 0.5×	244 0.4×	395 0.8×	358 1.1×	160 0.7×	46	832
Marzia Palma Sweden	18	366 0.4×	244 0.4×	549 1.1×	521 1.7×	292 1.3×	49	1.1k

Countries citing papers authored by Piers Patten

Since Specialization

Citations

This map shows the geographic impact of Piers Patten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piers Patten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piers Patten more than expected).

Fields of papers citing papers by Piers Patten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piers Patten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piers Patten. The network helps show where Piers Patten may publish in the future.

Co-authorship network of co-authors of Piers Patten

This figure shows the co-authorship network connecting the top 25 collaborators of Piers Patten. A scholar is included among the top collaborators of Piers Patten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piers Patten. Piers Patten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sanderson, Robin, Jane E. Norman, Joht Singh Chandan, et al.. (2025). CAR T access and outcomes in large B‐cell lymphoma according to ethnicity and socioeconomic deprivation in the UK. British Journal of Haematology. 206(4). 1178–1185. 1 indexed citations

Burger, Jan A., Paul M. Barr, Tadeusz Robak, et al.. (2025). Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL. Blood. 146(18). 2168–2176. 5 indexed citations

Walewska, Renata, Toby A. Eyre, Adrian Bloor, et al.. (2025). 2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia. British Journal of Haematology. 207(6). 2296–2313.

Sarma, Anita & Piers Patten. (2025). Chronic lymphocytic leukaemia. Medicine. 53(5). 298–303.

Friedman, Daniel, et al.. (2024). Proliferating CLL cells express high levels of CXCR4 and CD5. HemaSphere. 8(12). e70064–e70064. 2 indexed citations

Burger, Jan A., Paul M. Barr, Tadeusz Robak, et al.. (2024). CLL-076 Final Analysis of the RESONATE-2 Study: up to 10 Years of Follow-Up of First-Line Ibrutinib Treatment in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 24. S342–S343. 4 indexed citations

Burger, Jan A., Paul M. Barr, Tadeusz Robak, et al.. (2024). Final Analysis of the RESONATE-2 Study: Up to 10 Years of Follow-Up of First-Line Ibrutinib Treatment in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 24. S179–S179. 5 indexed citations

Figueroa, Rocío, Alexandros Rampotas, Daniel M. Halperin, et al.. (2023). Venetoclax ramp‐up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study. British Journal of Haematology. 202(1). 48–53. 6 indexed citations

Martínez‐Calle, Nicolás, et al.. (2023). The evolving use of measurable residual disease in chronic lymphocytic leukemia clinical trials. Frontiers in Oncology. 13. 1130617–1130617. 9 indexed citations

10.

Palmer, David A., Hannah C. Dooley, Menelaos Pipis, Piers Patten, & Eli Silber. (2022). A Novel approach using O-CVP to treat paraneoplastic NMO spectrum disorder associated with follicular lymphoma. BMJ Case Reports. 15(11). e252822–e252822.

11.

McKenzie, Duncan R., Rosalind Graham, Thomas Lechmere, et al.. (2022). Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with Cancer. Cancer Research Communications. 2(11). 1449–1461. 1 indexed citations

12.

Ioannou, Nikolaos, Mariela Sivina, Karen Clise-Dwyer, et al.. (2022). Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures. Leukemia. 36(5). 1324–1335. 12 indexed citations

13.

Salles, Gilles, Stephen J. Schuster, Martin Dreyling, et al.. (2022). Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma. Blood Advances. 6(22). 5835–5843. 26 indexed citations

14.

Kakkassery, Helen, et al.. (2022). Immunogenicity of SARS-CoV-2 vaccines in patients with cancer. Trends in Molecular Medicine. 28(12). 1082–1099. 14 indexed citations

15.

Hillmen, Peter, Rebecca H. Boucher, Nichola Webster, et al.. (2020). Continued Long Term Responses to Ibrutinib + Venetoclax Treatment for Relapsed/Refractory CLL in the Blood Cancer UK TAP Clarity Trial. Blood. 136(Supplement 1). 17–18. 13 indexed citations

16.

Hillmen, Peter, Andy C. Rawstron, Kristian Brock, et al.. (2019). Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study. Journal of Clinical Oncology. 37(30). 2722–2729. 180 indexed citations

17.

Patten, Piers, Gerardo Ferrer, Shih‐Shih Chen, et al.. (2016). Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6–deficient process. JCI Insight. 1(4). 28 indexed citations

18.

Bagnara, Davide, Matthew Kaufman, Carlo Calissano, et al.. (2011). A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood. 117(20). 5463–5472. 145 indexed citations

19.

Chu, Charles C., Lu Zhang, Sébastien Didier, et al.. (2011). Torque Teno Virus 10 Isolated by Genome Amplification Techniques from a Patient with Concomitant Chronic Lymphocytic Leukemia and Polycythemia Vera. Molecular Medicine. 17(11-12). 1338–1348. 13 indexed citations

20.

Buggins, Andrea G.S., Chris Pepper, Piers Patten, et al.. (2010). Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-κB Activation and De novo Gene Transcription. Cancer Research. 70(19). 7523–7533. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact